SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
561 To All: A clinician's perspective...As a neurologist I hate dealing with thjim black-1/21/1998
560 Just my take on the company now: The company's Avonex sales are at a pace Harold Engstrom-1/21/1998
559 Mike: I sure wish that I had been a lurker from the end of October until now. scaram(o)uche-1/21/1998
558 Hi, Rick, Yeh, I know about the genesis of your newsletter; it's been arounmike head-1/21/1998
557 Mike, good catch. I went back and looked at the same press release that PB posVector1-1/20/1998
556 Mike: Ugh. I've been promising a newsletter launch, from a bunch of on-liscaram(o)uche-1/20/1998
555 Mike, it seems it's idiopathic, at least in the company's press releasePseudo Biologist-1/20/1998
554 Rick and Vector1. A couple of questions. 1)V1- I thought the 'I' in ITPmike head-1/20/1998
553 Rick, I am looking forward to the BioPlatform launch and the CD40L discussion. Vector1-1/20/1998
552 Thanks, V1. That description is straight out of 1995. When we launch BioPlatfscaram(o)uche-1/20/1998
551 Rick, Some of the analysts are starting to pick up on the potential to the CD40Vector1-1/20/1998
550 Thanks Rick. HaroldHarold Engstrom-1/17/1998
549 Harold, I thought the 4th quarter Avonex numbers were impressive, however I do Vector1-1/17/1998
548 The balance sheet is very robust. The Smith Barney analyt referred to cash as Harold Engstrom-1/16/1998
547 Harold: You sort of lost me. But.... what I meant was.... I believe that Bscaram(o)uche-1/16/1998
546 Rick, do you mean that either Biogen or IMNX or some other company will commercHarold Engstrom-1/16/1998
545 [ clarification regarding last post ] The "violating open exchange" scaram(o)uche-1/16/1998
544 V1: Note that IMNX was also very vocal about being aggressive with the moleculscaram(o)uche-1/16/1998
543 Rick, I was at the BGEN main session. When going through the pipeline Tobin waVector1-1/16/1998
542 JP Morgan upgrades today to BUY. It looks like a retest of last years highs iStanley Cowen-1/16/1998
541 Yes, well, analysts rarely stand in front of a crowd and say "I'm sortscaram(o)uche-1/16/1998
540 Have you seen an electronic version of the Analyst's wrap yet? I'm notHenry Niman-1/16/1998
539 Analyst's wrap at H&Q today........ Richard van den Broek complimscaram(o)uche-1/16/1998
538 WOW! Ahead of concensus estimates (.39 for the quarter, 1.15 for the year). Tecpragat-1/15/1998
537 Company Press Release SOURCE: Biogen, Inc. Biogen Reports Record Fourth QuarterDubM-1/15/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News